Makers Laboratories Limited (NSE:MAKERSL)

India · Delayed Price · Currency is INR

182.88

+1.62 (0.89%)

At close: Sep 23, 2026

Market Cap	1.09B +30.8%
Revenue (ttm)	1.49B +17.8%
Net Income	34.19M -61.6%
EPS	5.79 -61.6%
Shares Out	n/a
PE Ratio	31.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,736
Open	182.00
Previous Close	181.26
Day's Range	180.10 - 187.89
52-Week Range	150.00 - 236.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Makers Laboratories

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, dig... [Read more]

Industry Pharmaceutical Preparations

Founded 1984

Employees 114

Stock Exchange National Stock Exchange of India

Ticker Symbol MAKERSL

Full Company Profile

Financial Performance

In fiscal year 2026, Makers Laboratories's revenue was 1.41 billion, an increase of 16.30% compared to the previous year's 1.21 billion. Earnings were 23.51 million, a decrease of -68.61%.

Financial Statements